Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
데이터 추가 비고
원인
When the user selects "yes" at the "new patient?" screen and the program was not changed prior to powering off the infuser the distal occlusion pressure setting is assigned a values of 15 psi (775 mmhg) instead of the default value. in addition the user interface will incorrectly display the default distal occlusion pressure value. the default value is set at 6 psi from the manufacturer. the user would not be immediatly aware of the unintended occlusion pressure setting unless the user views the current distal pressure value on the infuser display and it is greater that the distal pressure alarm limit. this may result in delay of therapy related to delay in identifying the occlusion cause.